ADVERTISEMENT
Search

ADVERTISEMENT
 

Pharmacy Today logo

New treatment option for pediatric T2D
Drugs & Diseases

Diabetes

New treatment option for pediatric T2D

This past June, FDA approved the first new class of medicines to treat pediatric T2D since 2000. Previously limited to metformin, children 10 years or older with T2D now have another treatment
option that can be used in addition to diet and exercise to improve blood glucose control.

Lauren Howell, PharmD

Pharmacists expand access to PrEP in 17 states
Practice & Trends

On the Cover

Pharmacists expand access to PrEP in 17 states

PrEP for HIV has made a significant impact in HIV prevention over the last decade. Since the combination of antiretrovirals tenofovir and emtricitabine (Truvada) earned FDA approval for the prevention of HIV in 2012, uptake among those for whom it is recommended has risen by an estimated 56% each year, according to data from Emory University’s Rollins School of Public Health. But major gaps remain between the number of people who could benefit from PrEP and the number who take it.

Sonya Collins

ACIP provides updates to several vaccinations
Practice & Trends

Immunization Update

ACIP provides updates to several vaccinations

ACIP gathered to discuss several vaccine recommendations in June 2023. As a result of the meeting, recommendations surrounding the influenza virus vaccine, adult respiratory syncytial virus (RSV) vaccine, polio virus vaccine, and pneumococcal vaccine for children, among others, were all updated.

Lauren Howell, PharmD

Cough, cold, and allergy
Practice & Trends

Self-care Product Survey

Cough, cold, and allergy

Approximately 1 billion cases of the common cold occur annually, making it one of the top five illnesses diagnosed in the United States. Bothersome symptoms lead patients to self-medicate, with an estimated $8 billion spent annually on nonprescription cold and cough products.

Unrecognized need to refrigerate etoposide capsules leads to wasted drug
Practice & Trends

Error Alert

Unrecognized need to refrigerate etoposide capsules leads to wasted drug

Etoposide capsules are a cold-chain medication used for small cell lung cancer that must be stored under refrigeration between 2°C and 8°C (36°F–46°F). A specialty pharmacy reported an error that resulted in a carton of etoposide 50 mg capsules being left out at room temperature overnight for about 12 hours.

Institute for Safe Medication Practices, Horsham, PA

RSS
First2324252628303132Last
ADVERTISEMENT